Testing effectiveness (Phase 2)WithdrawnNCT03973879What this trial is testingCombination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant GliomaWho this might be right forMalignant Glioma Darell Bigner
Testing effectiveness (Phase 2)Study completedNCT00004146What this trial is testingCarboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBMWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT01062399What this trial is testingEverolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors Radiation Therapy Oncology Group 279
Testing effectiveness (Phase 2)Study completedNCT02364206What this trial is testingStudy of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed GlioblastomaWho this might be right forAdult Glioblastoma Centre Jean Perrin 18
Testing effectiveness (Phase 2)Study completedNCT00003751What this trial is testingPenicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With GlioblastomaWho this might be right forBrain and Central Nervous System Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 40
Testing effectiveness (Phase 2)Study completedNCT00003301What this trial is testingIrinotecan in Treating Patients With Recurrent Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors New Approaches to Brain Tumor Therapy Consortium
Testing effectiveness (Phase 2)Study completedNCT00619112What this trial is testingTemozolomide in Treating Patients With Recurrent High-Grade GliomaWho this might be right forRecurrent Central Nervous System Neoplasm University of California, San Francisco 60
Large-scale testing (Phase 3)Study completedNCT00118222What this trial is testingHigh Light and Low Light Dose PDT in GliomaWho this might be right forBrain and Central Nervous System Tumors Case Comprehensive Cancer Center 1
Large-scale testing (Phase 3)Study completedNCT02667587What this trial is testingAn Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)Who this might be right forBrain Neoplasms Bristol-Myers Squibb 716
Early research (Phase 1)Study completedNCT00003463What this trial is testingCarmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade GliomasWho this might be right forBrain and Central Nervous System Tumors Duke University
Testing effectiveness (Phase 2)Study completedNCT00014300What this trial is testingGlufosfamide in Treating Patients With Recurrent Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors European Organisation for Research and Treatment of Cancer - EORTC 32
Early research (Phase 1)Ended earlyNCT00006773What this trial is testingBortezomib in Treating Patients With Recurrent GliomaWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00107237What this trial is testingAEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors Novartis Pharmaceuticals 16
Testing effectiveness (Phase 2)Study completedNCT00352313What this trial is testingATN-161 and Carboplatin in Treating Patients With Recurrent Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors National Institutes of Health Clinical Center (CC) 82
Testing effectiveness (Phase 2)Study completedNCT00070161What this trial is testingPhase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain TumorWho this might be right forBrain and Central Nervous System TumorsRadiation Toxicity Wake Forest University Health Sciences 68
Not applicableStudy completedNCT02060890What this trial is testingMolecular Profiling in Guiding Individualized Treatment Plan in Adults With Recurrent/Progressive GlioblastomaWho this might be right forAdult Glioblastoma University of California, San Francisco 20
Early research (Phase 1)Ended earlyNCT01122888What this trial is testingCilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma MultiformeWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+2 more National Cancer Institute (NCI) 41
Not applicableWithdrawnNCT00005790What this trial is testingPerfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain TumorsWho this might be right forBrain and Central Nervous System Tumors Northwestern University
Early research (Phase 1)UnknownNCT00002647What this trial is testingPhotodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain TumorsWho this might be right forBrain and Central Nervous System TumorsMetastatic Cancer Medical College of Wisconsin 24
Testing effectiveness (Phase 2)Ended earlyNCT01582152What this trial is testingPhase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent GlioblastomaWho this might be right forBrain NeoplasmsCentral Nervous System Neoplasms M.D. Anderson Cancer Center 12